LC
Laia Crespo
Partner at Sanofi Ventures
Paris, Île-de-France
Overview
Laia Crespo is a Partner at Sanofi Ventures in Paris, specializing in investing in companies at various stages, including Series A and Seed, primarily in the Boston/New England region. With an impressive background that includes roles at Ysios Capital, Johnson & Johnson, and UCB, Laia has invested in notable companies such as Eligo Bioscience and OMass Therapeutics, showcasing a strong track record of successful investments in the biotech sector.
Work Experience
Partner - Sanofi Ventures
2018 - Current
Current board member in Eligo Bioscience, Muna Therapeutics, NodThera, OMass Therapeutics, QurAlis, T-Therapeutics and Therini Bio. Previous investor / board member in Lava Therapeutics (LVTX)
Investment Director
2015 - 2018
Board Member in Minoryx, OxThera
Investment Manager
2009 - 2015
Board member in AM-Pharma, Inbiomotion
New Business Development Analyst for Europe, Middle East and Africa
2008 - 2009
Johnson & Johnson is a healthcare provider, expertise in innovative medicine and MedTech for every patient & for everyone.
Research Scientist
2007 - 2007
Research Scientist
2004 - 2007
Research Scientist
2002 - 2003